Clinical Trial

A Phase I Study of SIM0609 in Adult Participants With Locally Advanced/Metastatic Solid Tumors

Name: A Phase I Study of SIM0609 in Adult Participants With Locally Advanced/Metastatic Solid Tumors — clinical trial record (NCT07265921)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Study acronym: Solid Tumors

Recruiting Phase 1

View on ClinicalTrials.gov →

Summary

This is an open-label,multicenter phase I study to evaluate the safety,Tolerability, Pharmacokinetics and Preliminary Antitumor Activity of SIM0609 in Adult Participants with Locally Advanced/Metastatic Solid Tumors

Trial Details

NCT Number	NCT07265921
Lead Sponsor	Jiangsu Simcere Pharmaceutical Co., Ltd. Collaborators: Shanghai Xianwei Medical Technology Co., Ltd.
Conditions	Advanced Solid Cancer
Enrollment	232 participants
Start Date	2025-11-07
Primary Completion	2028-12 (estimated)
Study Completion	2029-06 (estimated)
Updated on ClinicalTrials.gov	2025-12-05